DName-iT Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
2
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$1.99M
- Investors
-
5
DName-iT General Information
Description
Developer of a genetic testing technology designed to avoid sample authentication errors. The company's core product molecules allow absolute control and automation of a broad range of tests in different fields in genetic labs, where one can confirm the patient's identity, avoiding independent patient validation steps such as additional SNP fingerprint testing, making the entire NGS workflow less time-consuming and more cost-efficient, enabling lab owners to test samples more effectively and efficiently.
Contact Information
Website
www.dnameit.comCorporate Office
- Concourse Building 3
- The Titanic Quarter, 6 Queens Road
- Belfast BT3 9DT
- Northern Ireland, United Kingdom
Corporate Office
- Concourse Building 3
- The Titanic Quarter, 6 Queens Road
- Belfast BT3 9DT
- Northern Ireland, United Kingdom
DName-iT Timeline
DName-iT Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC | 30-Jan-2026 | $1.99M | Completed | Generating Revenue | ||
| 4. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 3. Later Stage VC | 30-Jun-2023 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 07-Jan-2015 | Completed | Startup | |||
| 1. Early Stage VC | Completed | Startup |
DName-iT Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | ||||||||
| Ordinary Shares | ||||||||
| Ordinary Shares | 171,611 | $0.013508 | $2.31 | $2.31 | 1x | $2.31 | 7.95% | |
| Ordinary Shares | 182,482 | $0.013508 | $1.85 | $1.85 | 1x | $1.85 | 8.46% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
DName-iT Patents
DName-iT Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260327681-A1 | Methods for identification of samples | Pending | 11-Apr-2025 | ||
| GB-201701908-D0 | Methods for identification of samples | Inactive | 06-Feb-2017 | ||
| AU-2017266299-A1 | Methods for identification of samples | Inactive | 17-May-2016 | ||
| AU-2023229558-A1 | Methods for identification of samples | Active | 17-May-2016 | ||
| AU-2023229558-B2 | Methods for identification of samples | Active | 17-May-2016 | C12Q1/6869 |
DName-iT Signals
DName-iT Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BNP Paribas | Investment Bank | Minority | ||
| KBC Group | Corporation | Minority | ||
| KU Leuven Research & Development | University | Minority | ||
| MNL Nominees | Corporation | Minority | ||
| EMV Capital | Venture Capital | Minority |
DName-iT FAQs
-
When was DName-iT founded?
DName-iT was founded in 2014.
-
Where is DName-iT headquartered?
DName-iT is headquartered in Belfast, United Kingdom.
-
What is the size of DName-iT?
DName-iT has 2 total employees.
-
What industry is DName-iT in?
DName-iT’s primary industry is Laboratory Services (Healthcare).
-
Is DName-iT a private or public company?
DName-iT is a Private company.
-
What is the current valuation of DName-iT?
The current valuation of DName-iT is .
-
What is DName-iT’s current revenue?
The current revenue for DName-iT is .
-
How much funding has DName-iT raised over time?
DName-iT has raised $2.68M.
-
Who are DName-iT’s investors?
BNP Paribas, KBC Group, KU Leuven Research & Development, MNL Nominees, and EMV Capital have invested in DName-iT.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process